This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
這位cytokinetics分析師開始對看好的推薦進行覆蓋;以下是週五的前五個初始值。
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖,請參閱我們的分析師評級頁面。
- Guggenheim analyst Seamus Fernandez initiated coverage on Cidara Therapeutics, Inc. (NASDAQ:CDTX) with a Buy rating and announced a price target of $33. Cidara Therapeutics shares closed at $13.11 on Thursday. See how other analysts view this stock.
- RBC Capital analyst Leonid Timashev initiated coverage on Cytokinetics, Incorporated (NASDAQ:CYTK) with an Outperform rating and announced a price target of $80. Cytokinetics shares closed at $55.84 on Thursday. See how other analysts view this stock.
- Stephens & Co. analyst Sudan Loganathan initiated coverage on Immunome, Inc. (NASDAQ:IMNM) with an Overweight rating and announced a price target of $30. Immunome shares closed at $12.54 on Thursday. See how other analysts view this stock.
- Jefferies analyst Dennis Ding initiated coverage on Inhibikase Therapeutics, Inc. (NASDAQ:IKT) with a Buy rating and announced a price target of $8. Inhibikase Therapeutics shares closed at $2.78 on Thursday. See how other analysts view this stock.
- UBS analyst Ben Shelley initiated coverage on Flutter Entertainment plc (NYSE:FLUT) with a Buy rating and announced a price target of $306. Flutter Entertainment shares closed at $237.98 on Thursday. See how other analysts view this stock.
- 古根海姆分析師Seamus Fernandez給cidara therapeutics公司(納斯達克:CDTX)初始評級爲買入,並宣佈目標股價爲33美元。cidara therapeutics股價週四收於13.11美元。看看其他分析師對這支股票的看法。
- RBC Capital分析師Leonid Timashev給cytokinetics公司(納斯達克:CYTK)初始評級爲表現優異,並宣佈目標股價爲80美元。cytokinetics股價週四收於55.84美元。看看其他分析師對這支股票的看法。
- Stephens & Co.分析師Sudan Loganathan給immunome公司(納斯達克:IMNM)初始評級爲超重,並宣佈目標股價爲30美元。immunome股價週四收於12.54美元。看看其他分析師對這支股票的看法。
- Jefferies分析師Dennis Ding給inhibikase therapeutics公司(納斯達克:IKT)初始評級爲買入,並宣佈目標股價爲8美元。inhibikase therapeutics股價週四收於2.78美元。看看其他分析師對這支股票的看法。
- UBS分析師Ben Shelley給flutter entertainment plc公司(紐交所:FLUT)初始評級爲買入,並宣佈目標股價爲306美元。flutter entertainment股價週四收於237.98美元。看看其他分析師對這支股票的看法。
Considering buying CYTK stock? Here's what analysts think:
考慮購買CYTK股票嗎?以下是分析師的看法:
Read More:
閱讀更多:
- How To Earn $500 A Month From Nvidia Stock After Trump Win
- 特朗普獲勝後如何從英偉達股票賺取每月500美元
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。